IHI is a public-private partnership (PPP) between the EU and Europe’s health industries.

IHI is a public-private partnership (PPP) between the European Union (represented by the European Commission) and Europe’s health industries, namely the pharmaceutical, medical technology, biotechnology, digital health and vaccine industries. IHI's industry partners are the trade associations COCIR, EFPIA (including Vaccines Europe), EuropaBio, and MedTech Europe.

European Commission

The European Commission logoEuropean Commission`s Directorate General for Research and Innovation is responsible for the EU’s research, science and innovation policy. It aims to develop and implement R&I policies in order to improve Europe's competitiveness, boost its growth, create jobs, and tackle future societal challenges. The Commission monitors and contributes to the realisation of the European Research Area (ERA) and funds research in the EU and beyond through Horizon Europe, the EU’s key funding programme for research and innovation. Horizon Europe supports European Partnerships in which the EU, national authorities and the private sector jointly commit to support the development and implementation of research project activities.


COCIR COCIR logois the European trade association representing the medical imaging, radiotherapy, health ICT and electromedical industries. Founded in 1959, COCIR is a non-profit association headquartered in Brussels (Belgium) with a China Desk based in Beijing since 2007. COCIR is unique as it brings together the healthcare, IT and telecommunications industries. COCIR’s focus is to open markets for COCIR members in Europe and beyond. It provides a wide range of services on regulatory, technical, market intelligence, environmental, standardisation, international and legal affairs. COCIR is also a founding member of DITTA, the Global Diagnostic Imaging, Healthcare IT and Radiation Therapy Trade Association.


TheEFPIA logo European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the biopharmaceutical industry operating in Europe. Through its direct membership of 36 national associations, 39 leading pharmaceutical companies and a growing number of small and medium-sized enterprises (SMEs), EFPIA’s mission is to create a collaborative environment that enables our members to innovate, discover, develop and deliver new therapies and vaccines for people across Europe, as well as contribute to the European economy.

EuropaBioEuropaBio logo, the European Association for Bioindustries, promotes an innovative and dynamic European biotechnology industry. EuropaBio and its members are committed to the socially responsible use of biotechnology to improve quality of life; to prevent, diagnose, treat, and cure diseases; to improve the quality and quantity of food and feedstuffs and to move towards a biobased and zero-waste economy. EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which in turn, represent over 2600 biotech companies, 2300 of these being SMEs.
MedTech Europe

MedTech EuropMedTech Europe logoe is the European trade association for the medical technology industry including diagnostics, medical devices and digital health. Our members are national, European and multinational companies as well as a network of national medical technology associations who research, develop, manufacture, distribute and supply health-related technologies, services and solutions.

Vaccines Europe

Vaccines Europe Vaccines Europe logois a specialised vaccines group within the European Federation of Pharmaceutical Industries and Associations (EFPIA), the professional association of the innovative pharmaceutical industry in Europe. Vaccines Europe was created in 1991 to provide a voice for the vaccine industry in Europe. The group represents vaccine companies of all sizes operating in Europe, and currently includes all the major global innovative and research-based vaccine companies, including small and medium-sized enterprises. 
Our mission is to drive a sustainable and resilient vaccines environment in Europe, protecting people against infectious diseases at all stages of life.